Ezekowitz R A, Stahl P D
Children's Hospital Medical Center, Boston, MA 02115.
J Cell Sci Suppl. 1988;9:121-33. doi: 10.1242/jcs.1988.supplement_9.6.
Sugar-specific recognition is now well established as an important determinant of cell-cell interactions and host defence mechanisms. Macrophages, in particular, are known to express a variety of lectin-like proteins that are specific for oligosaccharides terminating in mannose, fucose, galactose and sialic acid. This review focuses on mannose recognition systems. Terminal mannose is rarely found on mammalian cell surfaces whereas it is ubiquitous on the surfaces of lower organisms. Mammals have evolved at least two mechanisms to recognize terminal mannose residues. These are, first, a mannose receptor located on the surface of macrophages and second, a mannose-binding protein found in blood plasma and secreted by hepatocytes. The mannose receptor is a 175K (K = 10(3) Mr) membrane glycoprotein. The receptor binds glycoproteins bearing high-mannose chains avidly at neutral pH but poorly at pH 5-6. The receptor recycles rapidly between the cell surface, where ligand binding occurs, and various acid intracellular compartments, where the ligand is discharged. The pH dependency of binding and the rapid recycling of receptor allow cells to accumulate many ligand molecules over an extended time. Endocytosis via this pathway appears to be regulated since mannose receptor expression is closely regulated. For example, the receptor is absent from monocytes but strongly expressed on 3- to 4-day-old monocyte-derived macrophages. Receptor expression can be up- and down-regulated by anti-inflammatory steroids and gamma interferon, respectively. The mechanisms are poorly understood as is the physiological basis for modulation. The mannose-binding protein is a large oligomeric plasma protein secreted by liver and present in significant amounts in serum. The basic subunit of the mannose-binding protein is a 32K protein, which shows homology with other lectin-like proteins, notably certain surfactant proteins of the lung. The structure of the mannose-binding protein has been deduced from sequence information and DNA cloning experiments. The elaboration of the mannose-binding protein by the liver is regulated; it appears to be an acute phase reactant. Recent evidence suggests that the mannose-binding protein may play some opsonic role in the recognition and killing of organisms. In this review, it is suggested that the mannose receptor and the mannose-binding protein operate 'hand in glove' to deal with infectious agents that express mannose on their surfaces.
糖特异性识别现已被确认为细胞间相互作用和宿主防御机制的重要决定因素。尤其是巨噬细胞,已知其表达多种凝集素样蛋白,这些蛋白对以甘露糖、岩藻糖、半乳糖和唾液酸结尾的寡糖具有特异性。本综述聚焦于甘露糖识别系统。末端甘露糖在哺乳动物细胞表面很少见,而在低等生物表面却普遍存在。哺乳动物已进化出至少两种识别末端甘露糖残基的机制。第一种是位于巨噬细胞表面的甘露糖受体,第二种是存在于血浆中且由肝细胞分泌的甘露糖结合蛋白。甘露糖受体是一种175K(K = 10³ Mr)的膜糖蛋白。该受体在中性pH下能 avidly 结合带有高甘露糖链的糖蛋白,但在pH 5 - 6时结合能力较差。受体在发生配体结合的细胞表面和各种酸性细胞内区室之间快速循环,在细胞内区室中配体被释放。结合的pH依赖性和受体的快速循环使细胞能够在较长时间内积累许多配体分子。通过该途径的内吞作用似乎受到调控,因为甘露糖受体的表达受到严格调控。例如,单核细胞中不存在该受体,但在3至4日龄的单核细胞衍生巨噬细胞上强烈表达。受体表达可分别被抗炎类固醇和γ干扰素上调和下调。其机制以及调节的生理基础尚不清楚。甘露糖结合蛋白是一种由肝脏分泌的大型寡聚血浆蛋白,在血清中含量丰富。甘露糖结合蛋白的基本亚基是一种32K蛋白,与其他凝集素样蛋白具有同源性,尤其是肺的某些表面活性蛋白。甘露糖结合蛋白的结构已根据序列信息和DNA克隆实验推导得出。肝脏对甘露糖结合蛋白的合成是受调控的;它似乎是一种急性期反应物。最近的证据表明,甘露糖结合蛋白可能在识别和杀灭生物体中发挥一些调理作用。在本综述中,有人提出甘露糖受体和甘露糖结合蛋白协同作用以应对表面表达甘露糖的感染因子。